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Chapter 22
The Interaction Between Plant Viroid-Induced Symptoms 
and RNA Silencing
Vicente Pallas, German Martinez, and Gustavo Gomez 
Abstract
A large body of evidence has lead to the suggestive proposal of a potential interplay between viroid-
induced pathogenesis and RNA silencing regulatory mechanisms. A variety of techniques have been used 
to examine this interaction. This chapter outlines the use of a green fluorescent protein (GFP) sensor, 
containing viroid-specific sequence targets to study this phenomenon. In addition, a symptomatic trans-
genic line of Nicotiana benthamiana that expresses and processes Hop stunt viroid (HSVd) is used as 
stocks in grafting assays with the rdr6i-Nb lines, in which the RNA-dependent RNA polymerase 6 
(NbRDR6) is constitutively silenced. The combination of the use of a viroid-specific GFP-sensor, the 
grafting assays with plants silenced for the RDR6 and the analysis of siRNAs allows one to address how to 
monitor viroid-specific RNA silencing and how to associate this regulatory pathway with symptom 
expression.
Key words: Agroinfection, Agroinfiltration, Green fluorescent protein, Viroid pathogenesis, RNA-
dependent RNA polymerase, RNA silencing
Viroids are the smallest known plant-restricted pathogenic RNAs. 
Viroid genomes consist of a single-stranded, covalently closed cir-
cular, noncoding, and non-encapsidated RNA, ranging from 246 
to 401 nucleotides in length (1–4). They are classified into two 
families; Pospiviroidae whose replication takes place in the nucleus, 
and Avsunviroidae that replicate and accumulate in the chloroplast 
(1). Given that viroids do not encode any pathogen-specific pro-
tein, their propagation and associated pathogenesis processes are 
fully dependent on the host biochemical machinery. This interac-
tion activates a sequence of poorly understood events that are 
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expressed as visible symptoms. It has long been accepted that the 
genomic RNA acts as the primary pathogenic effector via a direct 
interaction between specific viroid motifs and cellular factors (1, 5, 
6). However, the identification of viroid-specific small RNAs in 
viroid-infected plants has lead to a new attractive pathogenic model 
based on viroid-induced RNA silencing (7).
The possibility that RNA silencing may regulate viroid-induced 
pathogenic processes was enunciated a few years ago (8, 9). Later, 
it was shown that transgenic tomato plants expressing a partial-
length Potato spindle tuber viroid (PSTVd) RNA accumulated spe-
cific siRNAs and developed symptoms. Thus, it was proposed that 
the viroid-derived siRNAs might act as miRNAs to down-regulate 
the expression of physiologically important host genes and to 
induce disease-associated symptoms (7). Subsequently, indepen-
dent studies reinforced this pathogenesis model, thus supporting 
an emergent view in which viroid-induced RNA silencing would 
mediate the symptom expression in infected plants (10–15). 
Moreover, the recent demonstration that symptoms induced by 
Hop stunt viroid in Nicotiana benthamiana plants depend on 
RDR6 activity provides additional evidence linking RNA silencing 
and viroid pathogenesis (16).
In this chapter, we describe the methods employed in our lab-
oratory to: (1) analyze the viroid-induced RNA silencing activity in 
HSVd-infected N. benthamiana and cucumber plants and (2) cor-
relate the activity of a key component of diverse RNA silencing 
pathways (the RDR6 enzyme) with viroid symptom expression in 
infected plants.
 1. HSVd-Nb: in these assays, we used a symptomatic transgenic 
line of N. benthamiana that expresses and processes Hop stunt 
viroid (HSVd) (17, 18).
 2. Rdr6i-Nb: this is a transgenic line of N. benthamiana in which 
the expression of the RNA-dependent RNA polymerase 6 
(NbRDR6) is constitutively silenced (19). These plants were 
gently provided by the Prof. D. Baulcombe (The Sainsbury 
Laboratory, John Innes Centre, Norwich, UK).
 3. Wild-type N. benthamiana plants.
 4. Cucumber (Cucumis sativus Cv suyo).
 5. The N. benthamiana and C. sativus plants described in these 
assays were germinated and maintained until used, in a green-
house at 20–22°C.
2. Materials
2.1. Plant Material
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 1. Carborundum powder.
 2. Inoculation buffer: PO4Na 30 mM, pH 8.0.
 3. Parafilm.
 4. Razor blades.
 5. Plastic bags.
 6. Competent cells of Agrobacterium tumefaciens LBA4404 
transformed with dimeric HSVd (17).
 7. Luria–Bertani (LB) medium.
 8. LB-KTR medium: LB supplemented with antibiotics (100 mg 
rifampicin/ml, 5 mg tetracycline/ml, and 50 mg kanamycin/ml).
 9. Infiltration buffer: 50 mM MES [2-(N-morpholino)-ethane 
sulphonic acid] pH 5.6, 10 mM MgCl, and 100 mM 
acetosyringone.
 10. Syringes (1 ml).
 1. Extraction buffer: 0.1 M Tris–HCl (pH 9), 0.1 M NaCl, 
0.01 M EDTA, 0.1 M b-mercaptoethanol.
 2. Sterilized 1-ml Eppendorf tubes.
 3. Polytron.
 4. Plastic bags.
 5. Isopropanol.
 6. miRACLE™ miRNAs isolation Kit (STRATAGENE 400813. 
http://www.Stratagene.com).
 7. DEPC-treated water.
 8. Chloroform-isoamyl alcohol (49:1).
 1. 10× TBE stock solution: 108 g Tris base, 55 g boric acid, 
40 ml 0.5 M EDTA (pH 8.0), and distilled or deionized water 
to 1 l.
 2. TBE 1× working solution: dilute 100 ml of 10× TBE stock with 
900 ml of distilled or deionized water (dH2O) to make 1 l.
 3. Urea.
 4. Denaturing buffer: 5% urea in 1× TBE 0.5% Bromophenol 
blue.
 5. Electrophoresis apparatus (MINI-PROTEAN System, Bio-
Rad).
 1. Nylon membranes, positively charged.
 2. UV-cross linker or UV-transilluminator.
 3. Hybridization oven.
2.2. Viroid Inoculation
2.3. RNA Analysis
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 4. Maleic acid buffer: 0.1 M maleic acid, 0.15 M NaCl, adjust to 
pH 7.5 with NaOH.
 5. Blocking Reagent (Roche) 11096176001. Stock solution 10×: 
dissolve the blocking reagent (provided as powder) in maleic 
acid buffer to a final concentration 10% (w/v).
 6. 20× SSC: 3 M NaCl, 300 mM sodium citrate, pH 7.0.
 7. DIG Hybridization buffer:
For viroid mature forms. formamide 50% v/v, SSC 5×, 
N-laurylsarcosyne 0.1%, SDS 0.2%, Blocking reagent 1×.
For small RNAs. formamide 40% v/v, SSC 5×, N-laurylsarcosyne 
0.1%, SDS 0.2%, Blocking reagent (3×).
 8. DIG-labeled (−) strand HSVd-RNA probes.
 9. Washing buffer A: 2× SSC, 0.1% SDS.
 10. Washing buffer B: 0.1× SSC, 0.1% SDS.
 1. Blocking solution: 1× working solution: dilute 10× Blocking 
solution 1:10 with maleic acid buffer.
 2. Antibody solution: centrifuge anti-digoxigenin-AP and dilute 
1 in 104 in 1× Blocking solution.
 3. Washing buffer: 0.1 M maleic acid, 0.15 M NaCl, pH 7.5, 
0.3% (v/v) Tween 20.
 4. Maleic acid buffer: 0.1 M maleic acid, 0.15 M NaCl, adjust 
with NaOH to pH 7.5.
 5. Detection buffer: 0.1 M Tris–HCl (pH 9.5), 0.1 M NaCl.
 1. Competent cells of A. tumefaciens strain C58C1 transformed 
with HSVd-GFP reporter (10).
 2. Competent cells of A. tumefaciens C58C1 transformed with a 
GFP reporter gene (10).
 1. Confocal Laser Scanning Microscopy (Leica TCS SL).
 2. Microscope slides.
 3. Forceps with fine tips.
 1. Electrophoresis and blotting apparatus (for Western blots).
 2. Blotting membrane (recommend PDVF).
 3. 30% Acrylamide/bis-solutions, 37.5:1 mixture (Bio-Rad Cat 
#161-0158).
 4. SDS 10% (w/v): dissolve 10 g of SDS in 90 ml of dH2O with 
gentle stirring and bring to 100 ml with dH2O. Store at room 
temperature (RT).
Immunological Detection
2.4. RNA Silencing 
Analysis
2.4.1. Reporter Gene 
Expression
2.4.2. Reporter Gene 
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 5. 1.5 M Tris–HCl, pH 8.8: dissolve 27.23 g of Tris base in 80 ml 
of dH2O, adjust the pH to 8.8 with 6 N HCl. Bring the final 
volume to 150 ml with dH2O, autoclave, and store at RT.
 6. 0.5 M Tris–HCl, pH 6.8: dissolve 6 g of Tris base in 60 ml of 
dH2O, adjust the pH to 6.8 with 6 N HCl and bring the total 
volume to 100 ml with dH2O. Autoclave and store at RT.
 7. Running buffer 10× (stock solution) pH 8.3: 30.3 g Tris base, 
144.0 g glycine, 10.0 g SDS. Dissolve in dH2O and bring the 
total volume up to 1 l with deionized water. Store at RT.
 8. APS 10%: dissolve 100 mg of ammonium persulfate in 1 ml of 
deionized water.
 1. Protein transfer buffer (10× stock solution): dissolve 30.3 g of 
Tris and 144 g of glycine in 10× buffer, adjust to pH 8.3, and 
make up to a final volume of 1 l.
 2. Protein transfer buffer 1× (working solution): 100 ml of 10× 
buffer, 700 ml of dH2O, and 200 ml of methanol.
 3. TBS 10× (stock solution): dissolve 80 g of NaCl in 200 ml of 
1 M Tris–HCl, pH 7.6 and dilute to 1 l with distilled water.
 4. Wash buffer: Tween-TBS (TBS-T): dilute 1 ml of Tween 20 in 
1 l of 1× TBS.
 5. Blocking buffer: 5% defatted milk powder and 2% BSA in 
TBS-T.
 6. Primary Anti-GFP antibody (Rabbit-SIGMA G1544).
 7. Secondary antibody Anti-Rabbit, peroxidase-labeled 
(GE-Healthcare NA931).
 8. Orbital shaker.
 9. Forceps with rounded, non-serrated tips.
 10. X-ray film and cassettes.
 11. ECL Plus™ Detection Reagents (GE-Healthcare RPN 2132): 
ECL Plus Solution A, 100 ml; ECL Plus Solution B, 2.5 ml.
 12. Plastic bags.
 1. Dilute 200 mg of viroid RNA in 200 ml of inoculation buffer.
 2. Dust carborundum powder onto the cotyledons of 10- to 
15-day-old cucumber plants.
 3. Dispense 50 ml of inoculum mix onto each cotyledon, and 
 gently scrape with a yellow micropipette tip.
Blotting and Immunological 
Detection
3. Methods
3.1. Bioassays
3.1.1. Inoculation  
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 4. Place the inoculated plants in an environmentally controlled 
growing chamber at 22–24°C.
 5. After 4 days, move the inoculated plants to an environmentally 
controlled growing chamber at 28–30°C (optimal temperature 
for viroid-induced symptoms expression).
Here, we describe the method used to infect 2-week-old, wild-
type, and rdr6i N. benthamiana scions by grafting onto 8-week-
old HSVd-transgenic N. benthamiana stocks. Stunting is the most 
characteristic symptom induced by the expression of HSVd in N. 
benthamiana (17, 18). Thus, this phenotypic characteristic is used 
to determine symptom intensity in HSVd-infected plants. Grafting 
assays can be used to demonstrate whether or not the symptoms 
induced by a viroid infection are dependent on RDR6 activity, a 
key component of diverse RNA silencing pathways (Fig. 1).
 1. Remove the larger leaves from the stock and stake the plant 
with a stick.
 2. Cut an oblique, 0.5–0.7-cm-deep incision in the stock stem.
3.1.2. Grafting Inoculation [AU1]
Fig. 1. Wild-type and rdr6i-Nb transgenic line scions were grafted onto symptomatic HSVd/Nb stocks which are able to 
process and accumulate viroid mature forms (CM circular monomeric forms, LM linear monomeric forms). At 45 days after 
grafting, the infected wild-type scions (left ) showed severe stunting, reduced leaf size, and chlorosis, whereas the infected 
rdr6i scions (right ), accumulating HSVd at a similar level, were unable to develop viroid-characteristic symptoms. These 
findings suggest the requirement of RDR6 activity for the development of the viroid-induced pathogenic process indepen-
dently of viroid accumulation. C (−): wt/Nb and rdr6i/Nb scions grafted onto wt/Nb stocks as controls.
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 3. Select and cut a young growing tip with one or two leaves, 
from the scion.
 4. Insert the scion in the stock incision and fix the graft with 
Parafilm.
 5. Cover the grafted plant with a plastic bag and move the grafted 
plants to an environmentally controlled growth chamber at 
22–25°C.
 6. Check the grafted plant daily and make sure that the plastic 
bag is moist.
 7. After 4 days, make 2–3 holes in the plastic bag (see Note 1).
 8. After 2 days, remove the plastic bag.
 9. At 10 days after grafting, move the grafted plants to an envi-
ronmentally controlled growth chamber at 28–30°C (optimal 
temperature for the expression of viroid-induced symptoms).
Agroinoculation is a very easy method that permits efficient viroid-
inoculation in diverse hosts. The transcription of the dimeric 
viroid-RNA is controlled by the CaMV 35S promoter, allowing a 
high accumulation of viroid-RNA inoculum in the initial phase of 
the infection. A. tumefaciens strain C58C1, transformed with the 
binary plasmid pMog800, carrying the 35S-HSVd-tNos cassette, 
is used in this case as the inoculum source.
 1. Inoculate in 2 ml of liquid medium supplemented with specific 
antibiotics, single colonies of HSVd-transformed A. tumefa-
ciens grown on agar plates. Incubate the bacterial cultures for 
2 days at 28°C at 200 rpm on an orbital shaker.
 2. Transfer 2 ml of the bacterial culture to an Eppendorf tube and 
centrifuge (at 1,500 ×g for 4 min) in a microfuge at RT.
 3. Discard the supernatant and resuspend the bacterial pellet in 
2 ml of infiltration buffer and incubate for 1–2 h at 25°C.
 4. Agroinfiltrate the two basal leaves of the N. benthamiana 
plants, or the cotyledons for cucumber plants, by gentle pres-
sure infiltration through the stomata of the lower epidermis by 
using a 1-ml syringe without a needle.
 5. After infiltration, transfer the plants to an environmentally 
controlled growing chamber (28–30°C, 14 h of light).
 6. At 6 days post-infiltration, remove the agroinfiltrated leaves.
 7. Maintain the agroinoculated plants for 3–4 weeks under these 
conditions.
This protocol is a modification of the method previously reported 
(20). The total RNAs extracted by this method are used as inocu-
lum to infect cucumber plants and to analyze viroid mature forms 
by northern blot hybridization assays.
3.1.3. Agroinoculation
3.2. RNA Analysis
3.2.1. Total RNA 
Purification
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 1. Homogenize 150 mg of plant leaves in Extraction buffer at a 
ratio of 1:10 (w/v), in a plastic bag. [How is this done?]
 2. Transfer the homogenate to an Eppendorf tube and centrifuge 
at 12,000 × g for 3 min at RT.
 3. Transfer 1 ml of the supernate to a fresh Eppendorf tube, add 
500 ml (0.5 vol) of phenol/chloroform (1:1), and vortex vig-
orously for 1 min.
 4. Centrifuge at 12,000 × g for 5 min at RT.
 5. Transfer 500 ml of the aqueous phase to a fresh Eppendorf 
tube and add 500 ml of isopropanol.
 6. Incubate at RT for 5 min. Centrifuge at 12,000 × g for 15 min 
at 4°C. Discard the supernate.
 7. Air-dry the RNA pellet for 5 min and redissolve in 50 ml of 
sterile water (see Note 2).
 8. Store the RNA at −20°C.
The procedure used to obtain small RNA-enriched total RNAs 
consist of two steps. Firstly, total RNAs are extracted from infected 
plants by means of a modification of the original TRIzol protocol 
adapted to 15-ml tubes. To obtain higher recoveries of small RNAs, 
relative to total RNA, we use a pellet of total RNA as starting mate-
rial to obtain small RNA-enriched plant RNAs with a modified 
protocol adapted from the miRNA isolation kit (miRACLE™, 
STRATAGENE 400813) (steps 9–32). For the following proto-
col, autoclaved materials (tubes, caps, mortars, and pestles) are 
required.
 1. Place 2 g of plant tissue into a clean mortar, previously chilled 
with liquid nitrogen. Cover the tissue with liquid nitrogen and 
grind into a very fine powder while frozen.
 2. Transfer the powdered plant tissue to a clean 15-ml tube con-
taining 10 ml of TRIzol reagent. Mix well by vortexing and 
centrifuge at 12,000 × g for 10 min at 4°C to remove the insol-
uble material.
 3. Transfer the clear supernate to a fresh tube. Let the samples 
stand for 5 min at RT.
 4. Add 2 ml of chloroform, shake vigorously by hand for 15 s and 
allow to stand for 15 min at RT.
 5. Centrifuge the samples at 8,400 × g for 10 min at 4°C. The 
mixture will separate into three phases, the upper aqueous 
phase containing the RNA. Transfer this aqueous phase to a 
fresh tube.
 6. Repeat steps 4 and 5 until the white layer at the interphase 
disappears (this usually requires two repetitions).
 7. Transfer the aqueous phase to a fresh tube and add 0.5 vol of 
3 M sodium acetate, pH 5.6 and 0.5 volume of isopropanol.
[AU2]
3.2.2. Small RNA 
Purification from Leaves
[AU3]
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 8. Leave the samples for 20–30 min at RT and centrifuge at 
8,400 × g for 15 min at 4°C.
 9. Add 600 ml of miRACLE miRNA lysis buffer (provided in the 
kit) directly to the RNA pellet, obtained in the previous step, 
in order to dissolve it.
 10. Add a 0.1× volume of 2 M sodium acetate (pH 4) to the 
lysate.
 11. Add an equal volume of phenol to the lysate and mix well by 
inversion.
 12. Add a 0.2× volume of chloroform-isoamyl alcohol (49:1) equal 
lysate (for example, for lysates prepared in 600 ml of lysis buf-
fer, add 120 ml of chloroform-isoamyl alcohol). Cap the tube 
tightly and mix by shaking the tube vigorously for 10 s.
 13. Leave the mixture on ice for 15 min.
 14. Spin the mixture in a microfuge at 4°C at 16,000 × g for 20 min. 
After centrifugation, two phases should be clearly visible and 
some DNA and protein material may be visible at the 
interface.
 15. Carefully transfer the upper aqueous phase, containing the 
RNA, to a sterile, RNase-free microcentrifuge tube. Avoid tak-
ing any material from the interphase layer. Discard the lower 
phase, containing phenol, proteins, and DNA. Note the vol-
ume obtained.
 16. Add ethanol (96–100%) to the RNA solution to a final concen-
tration of 35% (v/v) (for example, add 215 ml of 96–100% 
ethanol to 400 ml of RNA solution). Mix well by vortexing.
 17. Place a miRACLE™ miRNA RNA-Binding Spin Cup in a 2-ml 
receptacle tube. Vigorously flex the hinge of the tube, so that 
it becomes flexible and the cap can be firmly seated after load-
ing. Transfer up to 700 ml of the RNA-containing 35% ethanol 
solution (from step 16) to the spin cup, close the cap securely 
and spin the cup.
 18. Spin the tube in a microcentrifuge at 16,000 × g for 60 s.
 19. Retain the filtrate (containing the small RNAs) in the receptacle 
tube and transfer the filtrate to a microfuge tube (see Note 3).
 20. Measure the final volume of the filtrate containing the small 
RNAs in 35% ethanol.
 21. Add ethanol (96–100%) to the filtrate solution to a final con-
centration of 70% (v/v) (for example, add 700 ml of 96–100% 
ethanol to 600 ml of filtrate). Mix well by vortexing. This ethanol 
concentration will bind sRNAs to the RNA-binding spin cup.
 22. Place a fresh miRACLE miRNA RNA-Binding Spin Cup in a 
fresh 2-ml receptacle tube. Transfer up to 700 ml of the RNA-
containing 70% ethanol solution (from step 14) to the spin cup 
and then cap the spin cup.
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 23. Spin the mixture in a microcentrifuge at 16,000 × g × 60 s 
(see Note 4).
 24. Remove and retain the spin cup and discard the filtrate.
 25. Add 600 ml of 1× miRACLE miRNA Low-Salt Wash Buffer 
(provided in the kit) to the spin cup. Centrifuge at 16,000 × g 
× 60 s. Remove and retain the spin cup and discard the filtrate. 
Replace the spin cup in the receptacle tube.
 26. Add a second 600 ml of the 1× miRACLE miRNA Low-Salt 
Wash Buffer to the spin cup. Centrifuge at 16,000 × g × 60 s. 
Remove and retain the spin cup and discard the filtrate. Replace 
the spin cup in the receptacle tube.
 27. Add 300 ml of the 1× miRACLE miRNA Low-Salt wash buffer 
to the spin cup. Centrifuge at 16,000 × g for 30–60 s. Remove 
and retain the spin cup and discard the filtrate. Replace the spin 
cup in the receptacle tube.
 28. Centrifuge at 16,000 × g for 2 min to dry the fiber matrix.
 29. Transfer the spin cup to a 1.5-ml microcentrifuge tube (pro-
vided) and discard the 2-ml receptacle tube.
 30. Add 50–100 ml of miRACLE™ miRNA elution buffer (pro-
vided in the kit) directly onto the center of the fiber matrix 
inside the spin cup. Incubate the tube at RT for 2 min.
 31. Spin the tube in a microcentrifuge at 16,000 × g for 1 min. 
Retain both the spin cup and the eluate, and reload it onto the 
membrane.
 32. Incubate the tube at RT for 2 min. Spin the tube in a micro-
centrifuge at 16,000 × g for 1 min. The purified RNA, enriched 
for small RNAs, is in the Elution Buffer in the microcentrifuge 
tube. The small RNA preparation can be stored at −20°C for 
up to 1 month, or at −80°C for long-term storage.
To obtain the maximum amount of phloem exudates, it is highly 
important to use well-hydrated plants, especially for viroid-infected 
plants; otherwise it may be difficult to extract these exudates.
 1. One day before the extraction, irrigate the plants excessively 
and transfer them to a less-stressful temperature (e.g. 25°C) 
for no less than 2 h (see Note 5).
 2. Make successive cuts in the leaf petioles, or the shoot apex, and 
collect the phloem exudate after each cutting (to get approx. 
50–100 ml of exudate) with a 10-ml pipette directly into 1 ml 
of TRIzol reagent (see Notes 6 and 7).
 3. Before starting the RNA extraction, it is recommended that 
the protein pellet is dissolved by vortexing vigorously, or by 
using a polytron (see Note 8).
 4. Leave the samples stand for 5 min at RT (to allow nucleopro-
tein complexes to dissociate).
3.2.3. Small RNA 
Purification from Phloem 
Exudates
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 5. Add 200 ml of chloroform per 1 ml of TRIzol and shake the 
samples vigorously for 15 s.
 6. Allow the samples to stand for 15 min at RT and centrifuge the 
resulting mixture at 12,000 × g for 15 min at 4°C.
 7. Transfer the upper aqueous phase to a fresh autoclaved 1.5-ml 
Eppendorf tube and add 250 ml of isopropanol per ml of 
TRIzol reagent.
 8. Mix gently and allow to stand for 5–10 min at RT.
 9. Centrifuge at 12,000 × g for 15 min at 4°C. Eventually, the 
RNA precipitate will form a transparent pellet on the bottom 
of the tube.
 10. Redissolve the pellet in sterile water. The expected RNA yield 
from 50 to 100 ml of phloem exudates is 10–50 ng.
To prepare homogeneous polymerized acrylamide gels, it is very 
important to wash all glass plates and materials with 70% ethanol 
and rinse with abundant sterile water. In this protocol, we describe 
the use of the mini-protean system (Bio-Rad); however, these 
directions could be adapted to different gel-casting systems.
 1. Adjust the short plate on the spacer-containing plate and fix 
into position with two clamps on the vertical side.
 2. Place the system on a stable support.
 3. Prepare a 5% denaturing acrylamide premix as follows. Gently 
mix (to avoid bubbles) the following components in the order 
indicated (the following volumes are sufficient for two mini 
gels): 2.5 ml of acrylamide/bis-acrylamide 40% (19:1); 500 ml 
of 10× TBE; 10 ml of sterile water; 9.6 g of urea; 100 ml of 
10% APS and 10 ml of TEMED (polymerization starts when 
the APS and TEMED are added).
 4. Gently pour the acrylamide mix between the plates and ensure 
that there are no bubbles in the gel.
 5. Insert a 10-well comb at the top of the gel and fill any empty 
space with acrylamide mix. Wait for 30 min at RT for complete 
polymerization.
 6. Remove the comb and clamps from the gel-casting system and 
place the gel in the electrophoresis system.
 7. Fill the tanks with cold fresh TBE 1× and flush out the sample 
wells using a micropipette.
 8. Mix 20 ml (~5 mg) of total RNAs with denaturing buffer (1:1) 
and incubate for 5 min at 85°C.
 9. Load the denatured samples into the sample wells and run the 
gel at 100 V at RT for 2 h.
3.2.4. Northern Blot 
Hybridization Analysis
For Viroid Mature Forms
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 10. Remove the short glass plate and place the gel carefully into 
ethidium bromide (1 mg/ml) staining solution. Allow to stain 
for 15 min, discard the staining solution and rinse the gel twice 
with sterile water for 5 min and visualize the gel under UV 
light.
 1. Prepare the 1× TBE buffer. Using buffer and H2O, chilled to 
4°C, will improve heat dissipation.
 2. Cut one corner of the gel to allow its orientation to be 
tracked.
 3. Cut the membrane and the filter paper to the dimensions of 
the gel. Always wear gloves when handling membranes to pre-
vent contamination. Equilibrate the gel and soak the mem-
brane, filter paper, and fiber pads in transfer buffer (15 min).
 4. Prepare the gel sandwich: place the cassette, with the gray side 
down, on a clean surface. Place one pre-wetted fiber pad on 
the gray side of the cassette and a sheet of filter paper on the 
fiber pad. Place the equilibrated gel on the filter paper and the 
pre-wetted membrane on the gel. Complete the sandwich by 
placing a piece of filter paper on the membrane. Add the last 
fiber pad (see Note 9).
 5. Close the cassette firmly, being careful not to move the gel and 
filter paper sandwich. Lock the cassette closed with the white 
latch.
 6. Place the cassette and add the frozen cooling unit into the 
module in the transfer unit and completely fill the tank with 
buffer.
 7. Add a standard magnetic stirrer bar to help maintain even buf-
fer temperature and ion distribution in the tank. Set the speed 
as fast as possible to keep ion distribution even. Run the blot 
for 1 h at 100 V.
 8. Upon completion of the run, dismantle the blotting sandwich 
and remove the membrane for hybridization.
 1. Place the membrane on Whatman 3MM-paper and UV-crosslink 
the membrane (0.18 J × 2.5 min).
 2. After the UV-crosslinking, rinse the membrane briefly with 
transfer buffer and allow it to air-dry.
 3. Pre-warm an appropriate volume of 1× DIG Hybridization 
buffer (10–15 ml/100 cm2 membrane) to the hybridization 
temperature (68°C).
 4. Pre-hybridize the membrane with 1× DIG Hybridization buf-
fer for 60 min with gentle agitation in an appropriate container 
(see Note 10).
RNA Blotting
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 5. Denature the DIG-labeled RNA probe by boiling for 5 min 
and cooling rapidly on ice.
 6. Add the denatured DIG-labeled RNA probe (100 ng/ml) to 
the pre-warmed 1× DIG Hybridization buffer (3.5 ml/100 cm2 
membrane) and mix.
 7. Discard the pre-hybridization solution and add the probe/
hybridization mixture to the membrane.
 8. Incubate overnight at 68°C with gentle agitation (see Note 11).
 9. Discard the probe and wash the membrane twice for 5 min in 
wash buffer A at RT with constant agitation.
 10. Wash the membrane twice for 15 min in wash buffer B (pre-
warmed to washing temperature) at 68°C under constant 
agitation.
 1. After hybridization and stringency washes, rinse the membrane 
briefly (1–5 min) in washing buffer.
 2. Incubate for 30 min in 100 ml of blocking solution.
 3. Incubate for 30 min in 50 ml of antibody solution.
 4. Wash 2× 15 min in 100 ml of washing buffer.
 5. Equilibrate 2–5 min in 100 ml of detection buffer.
 6. Place the membrane (with RNA side facing up) on a develop-
ment folder (or hybridization bag) and quickly apply approx. 
1 ml of CSDP solution.
 7. Cover the membrane with the second sheet of the folder to 
spread the substrate evenly, and without air bubbles, over the 
membrane.
 8. Incubate for 5 min at RT.
 9. Squeeze out the excess liquid and seal the edges of the devel-
opment folder around the damp membrane (see Note 12).
 10. Expose to an imaging device for 5–20 min or to X-ray film for 
15–25 min at RT (see Note 13). Representative northern blot 
assays for viroid mature forms are shown in the Figs. 1 and 2.
 1. Prepare a 20% denaturing acrylamide premix. Mix gently (to 
avoid bubbles) the following components in the order shown 
(indicated volumes allow for the preparation of two mini gels): 
10 ml of acrylamide/bis-acrylamide 40% (19:1); 500 ml of 10× 
TBE; 2.5 ml of sterile water; 9.6 g of urea; 100 ml of APS 
(10%) and 10 ml of TEMED (polymerization starts when the 
APS and TEMED are added).
 2. Mix 50 ml (~5 mg) of small-enriched RNA with 10 mg of urea 
and incubate for 5 min at 85°C.
Immunological Detection
For Viroid-Derived Small 
RNAs
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 3. Load the denatured samples into the sample wells and run the 
gel for 4 h at 85 V, at RT.
 4. Remove the gel from the electrophoresis system.
 5. Remove the short glass plate and carefully place the gel in an 
ethidium bromide staining solution. Stain for 15 min and care-
fully discard the staining solution. Rinse the gel twice with 
sterile water for 5 min and visualize under UV light.
 6. Cut off the top of the gel (containing the high-molecular-
weight RNAs) and discard.
Follow the identical procedure to that described above for the 
blotting of total RNAs, except that the blotting is only run for 2 h 
at 65 V.
RNA Blotting
Fig. 2. The HSVd-Nb plants expressing and processing a dimeric HSVd-RNA accumulate high levels of HSVd mature forms 
(CM circular monomeric forms, LM linear monomeric forms) and viroid-derived (vd) siRNAs. Left: HSVd/Nb plants were 
agroinfiltrated with HSVd-GFP and GFP constructs. The expression of the HSVd-GFP reporter gene was suppressed in this 
transgenic plant, unlike the unmodified GFP that showed normal fluorescence, indicating that (vd) siRNAs are functional 
and able to guide the specific cleavage of the full-length unstructured HSVd-RNA sequence. GFP green fluorescent 
protein.
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 1. Place the membrane on Whatman 3MM-paper and UV-crosslink 
the membrane (0.18 J × 2.30 min).
 2. After the UV-crosslinking, rinse the membrane briefly with 
transfer buffer and allow it to air-dry.
 3. Pre-warm an appropriate volume of DIG Hybridization buffer 
(10–15 ml/100 cm2 membrane) at 68°C (see Note 14).
 4. Pre-hybridize the membrane with DIG Hybridization buffer 
for 2 h with gentle agitation in an appropriate container at 
68°C.
 5. Denature the DIG-labeled RNA probe by boiling for 5 min 
and rapidly cooling on ice.
 6. Add the denatured DIG-labeled RNA probe (100 ng/ml) to 
pre-warmed DIG Hybridization buffer (3.5 ml/100 cm2 
membrane) and mix.
 7. Discard the pre-hybridization solution and add the probe/
hybridization mixture to the membrane.
 8. Incubate overnight at 32°C with gentle agitation (see Note 15).
 9. Wash the membrane twice for 15 min in wash buffer A at RT 
under constant agitation.
 10. Wash the membrane twice for 15 min in wash buffer A (pre-
warmed to the wash temperature) at 35°C under constant 
agitation.
Follow the identical procedure to that described above for immu-
nological detection in northern blot assays of total RNAs. A repre-
sentative detection by northern blot analysis of viroid-derived 
siRNAs is shown in the Fig. 2.
To analyze the viroid-induced RNA silencing activity, we designed 
a transcriptionally fused 5¢ HSVd-GFP silencing reporter gene 
used to agroinfiltrate HSVd-Nb and HSVd-infected Wt-Nb plants. 
In these plants, the mature forms of the HSVd could resist the 
HSVd-induced RNA silencing-mediated degradation, whereas the 
identical full-length HSVd sequences fused to the mRNA GFP 
could not. Consequently, the HSVd-GFP construct could be used 
as a reporter of the HSVd-specific RNA silencing activity, in the 
symptomatic plants. Although here we describe the use of a sensor 
system to detect the HSVd-induced RNA silencing, similar reporter 
constructs can be used to analyze the RNA silencing induced by 
other nuclear viroids.
Binary pMog800 plasmids, carrying the 35S-HSVd-GFP-tNos 
or 35S:GFP:t-Nos cassettes, are transformed into A. tumefaciens 
strain C58C1 containing the virulence helper plasmid pCH32 (21).
Hybridization
Immunological Detection
3.3. RNA Silencing 
Analysis
3.3.1. Reporter Gene 
Expression
Agroinfiltration
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 1. Two days prior to agroinfiltration, inoculate 2 ml of liquid 
medium, supplemented with specific antibiotics, with single 
colonies of HSVd-GFP- and HSVd-transformed A. tumefa-
ciens grown on agar plates. Incubate the bacterial cultures for 
2 days at 28°C at 200 rpm on an orbital shaker.
 2. Two days later, start new bacterial cultures by inoculating fresh 
medium with the old suspension cultures (1/200 ratio, v/v). 
Grow the new cultures under the same conditions for an addi-
tional day.
 3. After 24 h, transfer 2 ml of each bacterial culture to Eppendorf 
tubes and pellet the cells by centrifugation (1,500 × g for 4 min) 
in a microfuge at RT.
 4. Discard the supernatant and resuspend the cell pellet in 2 ml of 
infiltration buffer. Dilute the bacterial suspensions with infil-
tration buffer to a final OD600 of 0.2 and incubate for 1–2 h at 
25°C.
 5. Agroinfiltrate the two basal leaves of N. benthamiana plants by 
gentle pressure infiltration through the stomata of the lower 
epidermis by using a 1-ml syringe without a needle.
 6. After infiltration, transfer the plants into an environmentally 
controlled growing chamber (28°C, 14 h of light).
 1. Three days after agroinfiltration, cut approx. 5.5 mm2 leaf discs 
(three per leaf) and mount in water under glass cover slips for 
microscopy.
 2. Analyze the GFP expression with a confocal laser scanning 
microscope, with excitation at 488 nm and emission at 510–
560 nm. An example of the potential results is shown in Fig. 2.
These instructions assume the use of a Bio-Rad Mini Protean gel 
system. However, they are easily adaptable to other gel formats.
 1. Adjust the short plate on the spacer-containing plate and fix 
lock into position with two clamps on the vertical sides.
 2. Place the system on a stable support.
 3. Prepare a 12% SDS-PAGE premix. Mix gently (to avoid bub-
bles) the following components, in the order shown (the indi-
cated amounts are sufficient for preparing two 20 ml mini 
gels): 8 ml of acrylamide/bis-acrylamide (30%); 5 ml of 1.5 M 
Tris (pH 8.8); 6.6 ml of sterile water; 200 ml of 10% APS; and 
10 ml of TEMED (polymerization starts when APS and 
TEMED are added).
 4. Gently pour the acrylamide mix between the gel plates, leaving 
space for a stacking gel, and ensure that are there are no bubbles 
3.3.2. Reporter Detection
By Confocal Microscopy
By Western Blot Analysis
Gel Electrophoresis
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in the gel. Carefully overlay with 500 ml of water. The gel 
should polymerize in about 30 min.
 5. Pour off the water.
 6. Prepare the stacking gel (8 ml) by mixing: 1.3 ml of acrylam-
ide/bis-acrylamide 30%; 1.0 ml of 1.0 M Tris (pH 6.8); 5.5 ml 
of sterile water; 80 ml SDS 10%; 80 ml of APS 10%; and 5 ml of 
TEMED (polymerization starts when APS and TEMED are 
added).
 7. Use about 3 ml of this to quickly rinse the top of the gel and 
then pour the stacking gel mix and insert the comb. The stack-
ing gel should polymerize within 20–30 min.
 8. Prepare the running buffer by diluting 100 ml of the 10× run-
ning buffer with 900 ml of water.
 9. Add the running buffer to the upper and lower chambers of 
the gel unit.
 10. Once the stacking gel has set, carefully remove the comb and 
use a micropipette to wash the wells with running buffer.
 11. Complete the assembly of the gel unit and connect it to a 
power supply.
 12. Mix 45 ml of protein extract with 5 ml of sample buffer. Denature 
the sample (3 min at 95°C). Centrifuge for 15 s at maximum 
speed.
 13. Load the denatured samples in the well and run at RT for 2 h 
at 85 V.
 1. After electrophoresis is complete, turn off the power supply 
and remove the tank lid and carefully lift out the Inner 
Chamber Assembly. Pour off, and discard, the running buffer 
(see Note 16).
 2. Open the cams of the Clamping Frame. Pull the Electrode 
Assembly out of the Clamping Frame and remove the Gel 
Cassette Sandwiches.
 3. Remove the gels from the Gel Cassette Sandwich by gently 
separating the two plates of the gel cassette. The green, wedge-
shaped, plastic Gel Releaser may be used to help pry the glass 
plates apart (see Note 17).
 4. Run the sharp edge of the Gel Releaser, or a razor blade, along 
each spacer to separate the gel from the spacer. Remove the gel 
by floating it off the glass plate by immersing the gel and plate 
under transfer solution and agitating gently until the gel sepa-
rates from the plate.
 5. Fill the Bio-Ice cooling unit with water and store it in your 
laboratory freezer at −20°C until ready to use. After use, return 
the cooling unit to the freezer for storage.
Blotting
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 6. Prepare the protein-transfer buffer (see Note 18).
 7. Cut the PDVF membrane and the filter paper to the dimen-
sions of the gel. Always wear gloves when handling membranes 
to prevent contamination. Soak the PDVF membrane in 
methanol.
 8. Equilibrate the gel and soak the membrane, filter paper, and 
fiber pads in transfer buffer for 5 min.
 9. Prepare the gel sandwich: place the cassette, with the gray side 
down, on a clean surface. Place one pre-wetted fiber pad on 
the gray side of the cassette and a sheet of filter paper on the 
fiber pad. Place the equilibrated gel on the filter paper and the 
pre-wetted membrane on the gel. Complete the sandwich by 
placing a piece of filter paper on the membrane. Add the last 
fiber pad (see Note 9).
 10. Close the cassette firmly, being careful not to move the gel and 
filter paper sandwich. Lock the cassette closed with the white 
latch.
 11. Place the cassette in module.
 12. Add the frozen Bio-Ice cooling unit. Place the cassette in the 
tank and completely fill with buffer.
 13. Add a standard stir bar to help maintain even buffer tempera-
ture and ion distribution in the tank. Set the speed as fast as 
possible to keep ion distribution even.
 14. Put on the lid, plug the cables into the power supply, and run 
the blot for 1 h at 100 V.
 15. Upon completion of the run, dismantle the blotting sandwich 
and remove the membrane for development.
 1. Incubate the membrane in 50 ml of blocking buffer for 1 h at 
RT on a rocking platform.
 2. Discard the blocking buffer and add a 1:10,000 dilution of the 
anti-GFP in TBST/2% BSA for 7–9 h at 4°C on a rocking 
platform.
 3. Remove the primary antibody and wash the membrane three 
times for 10 min each with 50 ml of TBS-T.
 4. Prepare fresh secondary antibody, at a 1:10,000-fold dilution 
in blocking buffer, and add it to the membrane. Incubate for 
60 min at RT.
 5. Discard the secondary antibody and wash the membrane three 
times, for 15 min each, with TBS-T.
 6. During the final wash, 2-ml aliquots of each portion of the 
ECL reagent are warmed separately to RT and the remaining 
steps are done in a dark room under safe light conditions. Once 
the final wash is removed from the blot, mix the ECL reagents 
Blot Development
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and then immediately add them to the blot. Incubate at RT for 
5 min to ensure even coverage.
 7. Remove the blot from the ECL reagents and place it between 
the two pieces of plastic that has been cut to the size of an 
X-ray film cassette.
 8. Place the bag, containing the membrane, in an X-ray film cas-
sette with film for a suitable exposure time, typically for 
3–7 min.
 1. The holes in the plastic bag permit a gradual adaptation to 
environmental conditions.
 2. The pellet dissolution can be facilitated by incubation at 
55°C.
 3. If it is not possible to load the entire sample in the spin cup in 
step 9, reseat the same spin cup in the receptacle tube and 
repeat steps 9 and 10, combining all of the filtrates into a single 
tube.
 4. If the sample volume is greater than 700 ml, repeat steps 22 
and 23.
 5. Better results are obtained with an overnight exposure.
 6. Younger leaves from the apex, and the apex itself, are the pre-
ferred plant tissue to carry out phloem extraction. Before cut-
ting the petiole, clean the cut surface with sterilized filter paper 
to avoid cellular contamination.
 7. In infected plants, it is difficult to obtain more than 0.5–1 ml of 
phloem by cutting. Exudates form a whitish pellet due to pro-
tein precipitation.
 8. The removable parts of the polytron must be cleaned with SDS 
10% and ethanol, after each use.
 9. Remove any air bubbles which may have formed. Use a tube to 
gently roll out the air bubbles.
 10. Membranes should move freely, especially if several membranes 
are used in the same pre-hybridization solution.
 11. DIG Hybridization buffer containing DIG-labeled probe can 
be stored at −20°C and be reused when freshly denatured at 
65°C for 10 min.
 12. Ensure that the membrane does not dry out during exposure. 
Otherwise a dark background will be obtained.
4. Notes
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 13. Luminescence continues for at least 24 h. The signal increases 
in the first few hours. Multiple exposures can be taken to 
achieve the desired signal strength.
 14. To avoid background signal, it is important to use the DIG 
Hybridization buffer specific to small RNAs northern blots.
 15. In principle, DIG Hybridization buffer containing DIG-
labeled probe can be stored at −20°C and reused when freshly 
denatured at 65°C for 10 min. In northern blot assays to detect 
small RNAs, we do not recommend reusage of DIG 
Hybridization buffer containing RNA probes, due to the 
increase of the background signal.
 16. Always pour off the buffer before opening the cams to avoid 
spilling the buffer.
 17. To remove the gel from a Ready Gel Cassette, first slice the 
tape along the sides of the Ready Gel Cassette where the inner 
glass plate meets the outer plastic plate.
 18. Using buffer chilled to 4°C will improve heat dissipation.
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